0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tuberculosis (TB) Treatment Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-9U6180
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Tuberculosis TB Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Tuberculosis (TB) Treatment Market Research Report 2024

Code: QYRE-Auto-9U6180
Report
February 2024
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tuberculosis (TB) Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Tuberculosis (TB) Treatment Market

Tuberculosis (TB) Treatment Market

If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include:
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide
The global Tuberculosis (TB) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Treatment.

Report Scope

The Tuberculosis (TB) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis (TB) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis (TB) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tuberculosis (TB) Treatment Market Report

Report Metric Details
Report Name Tuberculosis (TB) Treatment Market
CAGR 5%
Segment by Type
  • Isoniazid
  • Rifampin (Rifadin, Rimactane)
  • Ethambutol (Myambutol)
  • Pyrazinamide
Segment by Application
  • Active TB
  • Latent TB
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd, Macleods Pharmaceutical Ltd, Dong-A ST Co., Ltd, Lupin Ltd, Janssen Products, LP, Mylan, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tuberculosis (TB) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tuberculosis (TB) Treatment Market report?

Ans: The main players in the Tuberculosis (TB) Treatment Market are Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd, Macleods Pharmaceutical Ltd, Dong-A ST Co., Ltd, Lupin Ltd, Janssen Products, LP, Mylan, Sanofi

What are the Application segmentation covered in the Tuberculosis (TB) Treatment Market report?

Ans: The Applications covered in the Tuberculosis (TB) Treatment Market report are Active TB, Latent TB

What are the Type segmentation covered in the Tuberculosis (TB) Treatment Market report?

Ans: The Types covered in the Tuberculosis (TB) Treatment Market report are Isoniazid, Rifampin (Rifadin, Rimactane), Ethambutol (Myambutol), Pyrazinamide

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Isoniazid
1.2.3 Rifampin (Rifadin, Rimactane)
1.2.4 Ethambutol (Myambutol)
1.2.5 Pyrazinamide
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Active TB
1.3.3 Latent TB
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis (TB) Treatment Market Perspective (2019-2030)
2.2 Tuberculosis (TB) Treatment Growth Trends by Region
2.2.1 Global Tuberculosis (TB) Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tuberculosis (TB) Treatment Historic Market Size by Region (2019-2024)
2.2.3 Tuberculosis (TB) Treatment Forecasted Market Size by Region (2025-2030)
2.3 Tuberculosis (TB) Treatment Market Dynamics
2.3.1 Tuberculosis (TB) Treatment Industry Trends
2.3.2 Tuberculosis (TB) Treatment Market Drivers
2.3.3 Tuberculosis (TB) Treatment Market Challenges
2.3.4 Tuberculosis (TB) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis (TB) Treatment Players by Revenue
3.1.1 Global Top Tuberculosis (TB) Treatment Players by Revenue (2019-2024)
3.1.2 Global Tuberculosis (TB) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis (TB) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis (TB) Treatment Revenue
3.4 Global Tuberculosis (TB) Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis (TB) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Treatment Revenue in 2023
3.5 Tuberculosis (TB) Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis (TB) Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis (TB) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis (TB) Treatment Breakdown Data by Type
4.1 Global Tuberculosis (TB) Treatment Historic Market Size by Type (2019-2024)
4.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2025-2030)
5 Tuberculosis (TB) Treatment Breakdown Data by Application
5.1 Global Tuberculosis (TB) Treatment Historic Market Size by Application (2019-2024)
5.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tuberculosis (TB) Treatment Market Size (2019-2030)
6.2 North America Tuberculosis (TB) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tuberculosis (TB) Treatment Market Size by Country (2019-2024)
6.4 North America Tuberculosis (TB) Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis (TB) Treatment Market Size (2019-2030)
7.2 Europe Tuberculosis (TB) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tuberculosis (TB) Treatment Market Size by Country (2019-2024)
7.4 Europe Tuberculosis (TB) Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size (2019-2030)
8.2 Asia-Pacific Tuberculosis (TB) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tuberculosis (TB) Treatment Market Size (2019-2030)
9.2 Latin America Tuberculosis (TB) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tuberculosis (TB) Treatment Market Size by Country (2019-2024)
9.4 Latin America Tuberculosis (TB) Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size (2019-2030)
10.2 Middle East & Africa Tuberculosis (TB) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Otsuka Pharmaceutical Co., Ltd
11.2.1 Otsuka Pharmaceutical Co., Ltd Company Detail
11.2.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Introduction
11.2.4 Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024)
11.2.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.3 Macleods Pharmaceutical Ltd
11.3.1 Macleods Pharmaceutical Ltd Company Detail
11.3.2 Macleods Pharmaceutical Ltd Business Overview
11.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Introduction
11.3.4 Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024)
11.3.5 Macleods Pharmaceutical Ltd Recent Development
11.4 Dong-A ST Co., Ltd
11.4.1 Dong-A ST Co., Ltd Company Detail
11.4.2 Dong-A ST Co., Ltd Business Overview
11.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Introduction
11.4.4 Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024)
11.4.5 Dong-A ST Co., Ltd Recent Development
11.5 Lupin Ltd
11.5.1 Lupin Ltd Company Detail
11.5.2 Lupin Ltd Business Overview
11.5.3 Lupin Ltd Tuberculosis (TB) Treatment Introduction
11.5.4 Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024)
11.5.5 Lupin Ltd Recent Development
11.6 Janssen Products, LP
11.6.1 Janssen Products, LP Company Detail
11.6.2 Janssen Products, LP Business Overview
11.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Introduction
11.6.4 Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2019-2024)
11.6.5 Janssen Products, LP Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Tuberculosis (TB) Treatment Introduction
11.7.4 Mylan Revenue in Tuberculosis (TB) Treatment Business (2019-2024)
11.7.5 Mylan Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Tuberculosis (TB) Treatment Introduction
11.8.4 Sanofi Revenue in Tuberculosis (TB) Treatment Business (2019-2024)
11.8.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Isoniazid
    Table 3. Key Players of Rifampin (Rifadin, Rimactane)
    Table 4. Key Players of Ethambutol (Myambutol)
    Table 5. Key Players of Pyrazinamide
    Table 6. Global Tuberculosis (TB) Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Tuberculosis (TB) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Tuberculosis (TB) Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Tuberculosis (TB) Treatment Market Share by Region (2019-2024)
    Table 10. Global Tuberculosis (TB) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Tuberculosis (TB) Treatment Market Share by Region (2025-2030)
    Table 12. Tuberculosis (TB) Treatment Market Trends
    Table 13. Tuberculosis (TB) Treatment Market Drivers
    Table 14. Tuberculosis (TB) Treatment Market Challenges
    Table 15. Tuberculosis (TB) Treatment Market Restraints
    Table 16. Global Tuberculosis (TB) Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Tuberculosis (TB) Treatment Market Share by Players (2019-2024)
    Table 18. Global Top Tuberculosis (TB) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Treatment as of 2023)
    Table 19. Ranking of Global Top Tuberculosis (TB) Treatment Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Tuberculosis (TB) Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Tuberculosis (TB) Treatment Product Solution and Service
    Table 23. Date of Enter into Tuberculosis (TB) Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Tuberculosis (TB) Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2019-2024)
    Table 27. Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2025-2030)
    Table 29. Global Tuberculosis (TB) Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Tuberculosis (TB) Treatment Revenue Market Share by Application (2019-2024)
    Table 31. Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Tuberculosis (TB) Treatment Revenue Market Share by Application (2025-2030)
    Table 33. North America Tuberculosis (TB) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Tuberculosis (TB) Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Tuberculosis (TB) Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Tuberculosis (TB) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Tuberculosis (TB) Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Tuberculosis (TB) Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Tuberculosis (TB) Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Tuberculosis (TB) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Tuberculosis (TB) Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Tuberculosis (TB) Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Tuberculosis (TB) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Johnson & Johnson Company Detail
    Table 49. Johnson & Johnson Business Overview
    Table 50. Johnson & Johnson Tuberculosis (TB) Treatment Product
    Table 51. Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)
    Table 52. Johnson & Johnson Recent Development
    Table 53. Otsuka Pharmaceutical Co., Ltd Company Detail
    Table 54. Otsuka Pharmaceutical Co., Ltd Business Overview
    Table 55. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product
    Table 56. Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)
    Table 57. Otsuka Pharmaceutical Co., Ltd Recent Development
    Table 58. Macleods Pharmaceutical Ltd Company Detail
    Table 59. Macleods Pharmaceutical Ltd Business Overview
    Table 60. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product
    Table 61. Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)
    Table 62. Macleods Pharmaceutical Ltd Recent Development
    Table 63. Dong-A ST Co., Ltd Company Detail
    Table 64. Dong-A ST Co., Ltd Business Overview
    Table 65. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product
    Table 66. Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)
    Table 67. Dong-A ST Co., Ltd Recent Development
    Table 68. Lupin Ltd Company Detail
    Table 69. Lupin Ltd Business Overview
    Table 70. Lupin Ltd Tuberculosis (TB) Treatment Product
    Table 71. Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)
    Table 72. Lupin Ltd Recent Development
    Table 73. Janssen Products, LP Company Detail
    Table 74. Janssen Products, LP Business Overview
    Table 75. Janssen Products, LP Tuberculosis (TB) Treatment Product
    Table 76. Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)
    Table 77. Janssen Products, LP Recent Development
    Table 78. Mylan Company Detail
    Table 79. Mylan Business Overview
    Table 80. Mylan Tuberculosis (TB) Treatment Product
    Table 81. Mylan Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)
    Table 82. Mylan Recent Development
    Table 83. Sanofi Company Detail
    Table 84. Sanofi Business Overview
    Table 85. Sanofi Tuberculosis (TB) Treatment Product
    Table 86. Sanofi Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)
    Table 87. Sanofi Recent Development
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tuberculosis (TB) Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Tuberculosis (TB) Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Isoniazid Features
    Figure 4. Rifampin (Rifadin, Rimactane) Features
    Figure 5. Ethambutol (Myambutol) Features
    Figure 6. Pyrazinamide Features
    Figure 7. Global Tuberculosis (TB) Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Tuberculosis (TB) Treatment Market Share by Application: 2023 VS 2030
    Figure 9. Active TB Case Studies
    Figure 10. Latent TB Case Studies
    Figure 11. Tuberculosis (TB) Treatment Report Years Considered
    Figure 12. Global Tuberculosis (TB) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Tuberculosis (TB) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Tuberculosis (TB) Treatment Market Share by Region: 2023 VS 2030
    Figure 15. Global Tuberculosis (TB) Treatment Market Share by Players in 2023
    Figure 16. Global Top Tuberculosis (TB) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Treatment as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Treatment Revenue in 2023
    Figure 18. North America Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Tuberculosis (TB) Treatment Market Share by Country (2019-2030)
    Figure 20. United States Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Tuberculosis (TB) Treatment Market Share by Country (2019-2030)
    Figure 24. Germany Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Tuberculosis (TB) Treatment Market Share by Region (2019-2030)
    Figure 32. China Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Tuberculosis (TB) Treatment Market Share by Country (2019-2030)
    Figure 40. Mexico Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Tuberculosis (TB) Treatment Market Share by Country (2019-2030)
    Figure 44. Turkey Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Johnson & Johnson Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)
    Figure 47. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)
    Figure 48. Macleods Pharmaceutical Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)
    Figure 49. Dong-A ST Co., Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)
    Figure 50. Lupin Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)
    Figure 51. Janssen Products, LP Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)
    Figure 52. Mylan Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)
    Figure 53. Sanofi Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Dengue Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26K6048
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ebola Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20L6129
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cytomegalovirus Infection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4F6384
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global IVD Infectious Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16N6009
Mon Apr 15 00:00:00 UTC 2024

Add to Cart